ask="0.5460"
ask_size="2000"
average_daily_volume="603534"
bid="0.1000"
bid_size="300"
book_value="0.8130"
change="+0.0000"
change_from_200_day_moving_average="-0.1285"
change_from_50_day_moving_average="0.0190"
change_from_52_week_high="-0.9200"
change_From_52_week_low="0.1689"
change_in_percent="+0.0000%"
close="0.4999"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.5350"
ebitda="-17.93M"
eps_estimate_current_year="-0.7800"
eps_estimate_next_quarter="0.0000"
eps_estimate_next_year="-0.5700"
ex_dividend_date="N/A"
float_shares="29656000"
high="0.5249"
high_52_weeks="1.4199"
last_trade_date="12/30/2016"
last_trade_price="0.4999"
last_trade_size="389"
last_trade_time="4:00pm"
low="0.4909"
low_52_weeks="0.3310"
market_capitalization="15.01M"
moving_average_200_day="0.6284"
moving_average_50_day="0.4809"
name="OncoGenex Pharmaceuticals Inc."
notes="N/A"
one_year_target_price="0.9000"
open="0.5000"
pe_ratio="N/A"
peg_ratio="0.0000"
percent_change_from_200_day_moving_average="-20.4524%"
percent_change_from_50_day_moving_average="+3.9548%"
percent_change_from_52_week_high="-64.7933%"
percent_change_from_52_week_low="+51.0272%"
previous_close="0.4999"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="0.6149"
price_per_sales="1.3537"
revenue="11.09M"
shares_outstanding="30020000"
short_ratio="1.2200"
stock_exchange="NCM"
symbol="OGXI"
volume="286429"
weeks_range_52="0.3310 - 1.4199"
